StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — Osho Krishan, Angel One

BUYEmcure Pharmaceuticals Limited
Emcure Pharmaceuticals share price target & all analyst calls

byOsho Krishan, Angel OneHorizon: NA (inferred Swing (≤2wk))23 Oct 2026via Zee Business (Live)

Entry₹1,765.4Inferred
Target₹1,840
Total upside +4.23%
Stop loss₹1,700-3.70% risk
CMP₹1,770.4Just now
Active+0.28%+3.93%upside left 13d left
Follow Osho Krishan for new calls(29% target hit, 168 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 152 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 4:27 pm IST
2 supporting2 neutral1 opposing
Supports the BUY call (2)

RSI at 22 — oversold territory

Technicals · rsi·23 Oct · today

Emcure Pharma Shares May Rally Up To 33%, Says MOFSL On Strong Growth Outlook; Check Target Price

NewsNdtv-Profit·22 Oct · yesterday

(opens in new tab)
Neutral / worth noting (2)

Q2 FY27 results scheduled — board meets 03 Nov 2026

BSE · Board Meeting·In 11 days

(opens in new tab)

Emcure Pharmaceuticals has proposed a scheme of amalgamation for its wholly owned subsidiaries, Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited, into the parent company.

BSE · Company Update·12 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·23 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Emcure Pharmaceuticals

All analyst calls on Emcure Pharmaceuticals

More from Osho Krishan, Angel One

Every call and its outcome